IR-Med Gestion

Gestion contrôle des critères 2/4

We currently do not have sufficient information about the CEO.

Informations clés

Ran Ziskind

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	less than a year
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	3.6yrs
Durée moyenne du mandat des membres du conseil d'administration	3.9yrs

Mises à jour récentes de la gestion

Recent updates

PDG

Ran Ziskind

less than a year

Titularisation

Mr. Ran Ziskind is Chief Executive Officer of IR-Med Inc. from September 1, 2024. Mr. Ziskind is a highly experienced high-tech innovator and company leader with two decades of expertise in launching, deve...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.16% $ 4.3m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.1% $ 3.9m
Aharon Binur	Chief Development Officer	3.6yrs	US$252.67k	0% $ 0
Ran Ziskind	Chief Executive Officer	less than a year	pas de données	pas de données
Yaniv Cohen	Co-Founder	1.8yrs	pas de données	11.1% $ 3.9m
Sharon Levkoviz	CFO, Treasurer & Secretary	3.9yrs	pas de données	0% $ 0
Avi Vachnis	Head of Software & AI	3.3yrs	pas de données	pas de données

3.6yrs

Durée moyenne de l'emploi

60yo

Âge moyen

Gestion expérimentée: IRME's management team is considered experienced (3.6 years average tenure).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.16% $ 4.3m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.1% $ 3.9m
Yaniv Cohen	Co-Founder	3.9yrs	pas de données	11.1% $ 3.9m
Ohad Bashan	Director	3.9yrs	pas de données	0% $ 0
Richard Serbin	Member of Advisory Board	1.2yrs	pas de données	pas de données
Ron Mayron	Independent Director	3.9yrs	US$78.50k	0% $ 0
David Levy	Director of IR-Med Ltd	9.8yrs	pas de données	pas de données
Lynn Eschenbacher	Member of Advisory Board	no data	pas de données	pas de données
Avital Rosenberg	Independent Director	less than a year	pas de données	pas de données

3.9yrs

Durée moyenne de l'emploi

62yo

Âge moyen

Conseil d'administration expérimenté: IRME's board of directors are considered experienced (3.9 years average tenure).

IR-Med Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

PDG

Titularisation

Équipe de direction

Durée moyenne de l'emploi

Âge moyen

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen